Table 2.
Final predictors included in the models.
| Category | Number of predictors | Number of predictors selected multiple times | Predictors selected multiple timesa |
|---|---|---|---|
| Patient | 21 | 9 | Age, sex, ethnicity, performance score, year of diagnosis, family history, smoking, residency, and addiction to opium |
|
| |||
| Disease status | 34 | 21 | T stage, N stage, TNM stage, tumor site, tumor size, differentiation, metastasis, histologic type, Lauren type, LN ratio, lymphovascular invasion, bone metastasis, Borrmann type, liver metastasis, number of metastasis sites, lung metastasis, number of examined LN, metastasis LN, perineural invasion, LODDS, and TTP after chemotherapy |
|
| |||
| Biomarker | 116 | 19 | CEA, NLR, ALP, albumin, bilirubin, CA199, Hb, CES1, IS, LDH, LNR:ART, lymphocyte count, MGAT5, mGPS, NPTM, platelet, sodium, TNFRSF11A, and WBC |
|
| |||
| Treatment | 9 | 6 | Chemotherapy, gastrectomy, lymphedenectomy, resection margin, extent of resection, and radiotherapy |
aThe table lists only the predictors that have been included more than once. LN: lymph node. LODDS: log odds of positive LN. CEA: carcinoembryonic antigen. NLR: neutrophil/lymphocyte ratio. ALP: alkaline phosphatase. Hb: hemoglobin. MGAT5: β1, 6-N-acetylglucosaminyltransferase-5. mGPS: modified Glasgow Prognostic Score. CA199: cancer antigen 199. NPTM: number of positive tumor markers (cancer antigen 125, CA199, CEA). WBC: white blood cell. TTP: time to progression.